Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Express Scripts
Farmers Insurance
US Department of Justice
Deloitte
Teva
Cantor Fitzgerald
McKinsey
Merck

Generated: December 19, 2018

DrugPatentWatch Database Preview

Amneal Pharm Company Profile

« Back to Dashboard

Summary for Amneal Pharm

Drugs and US Patents for Amneal Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Ny SILDENAFIL CITRATE sildenafil citrate TABLET;ORAL 202023-002 Jun 27, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 205619-001 May 17, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF cetirizine hydrochloride SYRUP;ORAL 090765-001 Oct 7, 2009 OTC No No ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 204178-001 Dec 11, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms CELECOXIB celecoxib CAPSULE;ORAL 208833-003 May 31, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms Co PHENYLEPHRINE HYDROCHLORIDE phenylephrine hydrochloride SOLUTION;INTRAVENOUS 211078-002 Jul 19, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms Ny GABAPENTIN gabapentin CAPSULE;ORAL 078428-001 Jul 25, 2007 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for AMNEAL PHARM drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16

Supplementary Protection Certificates for Amneal Pharm Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB02/011 United Kingdom ➤ Try a Free Trial PRODUCT NAME: SEVELAMER; REGISTERED: UK EU/1/99/120/001-004 20000202
2008 00035 Denmark ➤ Try a Free Trial PRODUCT NAME: SITAGLIPTIN VALGFRIT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT, ISAER MONOPHOSPHAT, METFORMIN VALGFRIT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT, ISAER HYDROCHLORID
2014 00037 Denmark ➤ Try a Free Trial PRODUCT NAME: ET KOMBINATIONSPRODUKT AF DAPAGLIFLOZIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, HERUNDER DAPAGLIFLOZINPROPANDIOLMONOHYDRAT OG METFORMIN ELLER SALTE DERAF, HERUNDER METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/13/900 20140116
C0046 Belgium ➤ Try a Free Trial PRODUCT NAME: DOXORUBICIN HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/96/011/001 19960624
2011005,C0984957 Lithuania ➤ Try a Free Trial PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126
00132 Netherlands ➤ Try a Free Trial PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NATL REGISTRATION: RVG 28626 20030418; FIRST REGISTRATION: DE 54486.00.00, 54487.00.00, 54488.00.00, 54489.00.00 20021017
C0055 France ➤ Try a Free Trial PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
McKesson
Cipla
UBS
Merck
Mallinckrodt
Moodys
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.